US Patent 8545837 Methods and compositions for CNS delivery of iduronate-2-sulfatase
Patent 8545837 was granted and assigned to Shire (pharmaceutical company) on October, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08545837 Methods and compositions for CNS delivery of iduronate-2-sulfatase US Patent 8545837 Methods and compositions for CNS delivery of iduronate-2-sulfatase
Infobox
Patent Number
085458370
Patent Number
85458370
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
085458370
Date of Patent
October 1, 2013
0Patent Application Number
131689660
Date Filed
June 25, 2011
0Patent Primary Examiner
Edits on 18 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08545837 Methods and compositions for CNS delivery of iduronate-2-sulfatase
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08545837
Date of patent
October 1, 2013
Patent application number
13168966
Date Filed
June 25, 2011
Patent primary examiner
Find more entities like US Patent 8545837 Methods and compositions for CNS delivery of iduronate-2-sulfatase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
